Discontinuation of Naropin® with Fentanyl Injection Bags

HPS Pharmacies wishes to advise that Aspen Pharmacare Australia is discontinuing Naropin^® with Fentanyl injection bags as follows:

Naropin^® 0.2% with Fentanyl 200 (100mL)
Ropivacaine hydrochloride 2mg/mL + fentanyl 2 microgram/mL
ARTG 72874

Naropin^® 0.2% with Fentanyl 400 (100mL)
Ropivacaine hydrochloride 2 mg/mL + fentanyl 4 microgram/mL
ARTG 72876

Naropin^® 0.2% with Fentanyl 400 (200mL)
Ropivacaine hydrochloride 2 mg/mL + fentanyl 2 microgram/mL
ARTG 72873

Naropin^® 0.2% with Fentanyl 800 (200mL)
Ropivacaine hydrochloride 2 mg/mL + fentanyl 4 microgram/mL
ARTG 72875

There will be a reduction in supply until warehouse supplies are exhausted.

There are no alternatives available in the market. However, individual presentations of each active ingredient are available. It is recommended that relevant hospital protocols are reviewed and updated, as required.

Retain this notice in a prominent position, including in other related business units for at least one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Aspen Pharmacare on 1300 659 646 or your pharmacist at HPS Pharmacies.

Download PDF